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ABSTRACT 
Inflammation plays an important role in cancer development through a variety of 
mechanisms.  It has been shown that dysregulation of microRNAs (miRNAs) that function 
as oncogenes or tumor suppressors contributes to tumorigenesis.  However, the 
relationship between inflammation and cancer-related miRNA expression in tumorigenesis 
has not yet fully understood.  Using K19-C2mE and Gan mouse models that develop 
gastritis and gastritis-associated tumors, respectively, we found that 21 miRNAs were 
upregulated, and that 29 miRNAs were downregulated in gastric tumors in an 
inflammation-dependent manner.  Among these miRNAs, the expression of miR-7, a 
possible tumor suppressor, significantly decreased in both gastritis and gastric tumors.  
Moreover, expression of miR-7 in human gastric cancer was inversely correlated with the 
levels of IL-1 and TNF-, suggesting that miR-7 downregulation is related to the severity 
of inflammatory responses.  In the normal mouse stomach, miR-7 expression was at a 
basal level in undifferentiated gastric epithelial cells, and was induced during 
differentiation.  Moreover, transfection of a miR-7 precursor into gastric cancer cells 
suppressed cell proliferation and soft agar colony formation.  These results suggest that 
suppression of miR-7 expression is important for maintaining the undifferentiated status of 
gastric epithelial cells, and thus contributes to gastric tumorigenesis.  Although epigenetic 
changes were not found in the CpG islands around miR-7-1 of gastritis and gastric tumor 
cells, we found that activated macrophage-derived small molecule(s) (< 3 kDa) are 
responsible for miR-7 repression in gastric cancer cells.  Furthermore, the miR-7 
expression level significantly decreased in the inflamed gastric mucosa of 
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Helicobacter-infected mice, while it increased in the stomach of germfree K19-C2mE and 
Gan mice where the inflammatory responses were suppressed.  Taken together, these 
results indicate that downregulation of tumor suppressor miR-7 is a novel mechanism by 
which the inflammatory response promotes gastric tumorigenesis. 
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Introduction 
It has been established that inflammatory responses contribute to cancer development 
through a variety of mechanisms (Coussens and Werb, 2002).  The expression of 
cyclooxygenase-2 (COX-2), a rate-limiting enzyme for prostaglandin biosynthesis, plays an 
important role in both inflammation and cancer (Wang and DuBois, 2010).  Using genetic 
mouse models, we previously demonstrated that induction of COX-2 and its downstream 
product, prostaglandin E2 (PGE2), is required for gastrointestinal tumorigenesis (Sonoshita 
et al., 2001; Oshima et al., 2006).  The COX-2/PGE2 pathway, together with a bacterial 
infection, induces inflammatory responses in the stomach through the recruitment of 
macrophages, which promotes gastric tumorigenesis (Oshima et al., 2011).  However, it 
remains to be fully elucidated precisely how such inflammatory responses contribute to the 
promotion of gastric tumors.  
MicroRNAs (miRNAs) are a class of single-stranded small noncoding RNAs that 
regulate gene expression by post-transcriptional interference of the specific mRNAs 
(Ambros, 2004; Bartel, 2004).  Through their regulation of cancer-related gene expression, 
miRNAs can function as either oncogenes or tumor suppressors (Esquela-Kerscher and 
Slack, 2006; Ventura and Jacks, 2009).  The dysregulation of miRNAs in cancer has been 
shown to be associated with genomic/epigenetic alterations or 
transcriptional/post-transcriptional mechanisms (Di Leva and Croce, 2010).  Moreover, 
expression of several miRNAs, including oncogenic miRNAs, has been shown to be 
induced by inflammatory responses (Sonkoly and Pivarcsi, 2011).  For example, miR-155 
is induced in macrophages by NF-B, interferon (IFN)-, or Toll-like receptor signaling 
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(Tili et al., 2007; O’Connell et al., 2007), while miR-21 is induced by Stat3, a transcription 
factor activated by IL-6 (Ilipoulos et al., 2010).  On the other hand, the mechanism 
responsible for the downregulation of tumor suppressor miRNA expression in the 
inflammatory microenvironment has not been fully understood. 
We herein examined the expression of miRNAs in mouse models of gastritis and 
gastric tumors, which were developed in K19-C2mE mice and Gan mice, respectively 
(Oshima et al., 2004; Oshima et al., 2006).  We found the expression level of miR-7 to 
significantly decrease in gastric tumors in an inflammation-dependent manner.  It has been 
shown that miR-7 plays a tumor suppressor role in several cancers, including glioblastoma, 
breast cancer, and lung cancer (Kefas et al., 2008; Reddy et al., 2008; Webster et al., 2009; 
Jiang et al., 2010; Saydam et al., 2011).  In this manuscript, we demonstrate that miR-7 is 
induced during the differentiation of normal gastric epithelial cells, and it also plays a 
tumor suppressor role in the stomach.  These results suggest that downregulation of tumor 
suppressor miR-7 is one of the tumor-promoting mechanisms underlying the role of 




Inflammation-dependent dysregulation of miRNAs in gastric tumors 
To examine whether miRNA expression is dysregulated in gastric tumors by inflammatory 
responses, we examined the miRNA expression profiles in wild-type mouse stomachs from 
the K19-C2mE mouse gastritis and the Gan mouse gastric tumors by a microarray analysis.  
In Gan mouse gastric tumors, 50 miRNAs were upregulated (>2.0 fold), while 42 miRNAs 
were downregulated (< 0.5 fold) compared with the wild-type mouse stomach level (Figure 
1a and Supplementary Table 1).  Notably, 21 and 29 miRNAs showed upregulation or 
downregulation, respectively, in both gastritis and gastric tumors.  It is therefore possible 
that dysregulation of these miRNAs is caused by inflammatory responses.   
We confirmed the results of the microarray analysis by real-time RT-PCR.  Ten 
miRNAs randomly selected from the upregulated and downregulated miRNAs (Figure 1a, 
boxed) showed the same dysregulation pattern in both gastritis and gastric tumors (Figure 
1b).  Importantly, miR-155 and miR-21, which function as oncogenes (Volinia et al., 
2006) were upregulated, whereas miR-145 and miR-7, which function as tumor suppressors 
(Sachdeva et al., 2009; Kefas et al., 2008), were downregulated in both gastritis and gastric 
tumors (Figure 1a, b).  This suggests that inflammation can induce not only upregulation 
of oncogenic miRNAs, but also downregulation of tumor suppressor miRNAs. 
We next picked up 74 miRNAs that were not dysregulated in K19-C2mE gastritis 
compared with wild-type normal stomach (Supplementary Table 2).  Among them, 3 
miRNAs were upregulated in Gan mouse tumors compared with K19-C2mE gastritis tissue 
samples (> 2.0 fold), while 3 miRNA were downregulated (< 0.5 fold) (Figure 1c).  It is 
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possible that expression of these miRNAs is dysregulated by carcinogenesis-specific 
mechanisms.  
 
Induction of miR-7 during differentiation of gastric epithelial cells 
We further examined the expression of miR-7, because its role(s) in the normal stomach 
and gastric cancer have never been examined.  Gastric glands were isolated from the 
stomachs of the respective mouse models, and the miR-7 expression was examined by 
real-time RT-PCR.  Notably, the miR-7 levels were significantly lower in the epithelial 
cells of K19-C2mE gastritis tissues and Gan mouse tumors compared with the wild-type 
mouse stomach (Figure 2a), indicating that miR-7 is predominantly expressed in epithelial 
cells in an inflammation-dependent manner.   
When the primary cultured gastric epithelial cells were passaged and maintained for 6 
days, the cell morphology appeared to be differentiated, with enlarged and 
mucin-containing cytoplasm (Figure 2b).  Consistently, the expression of differentiation 
markers, Muc6 and Muc5AC, was elevated on day 6, whereas the expression of the Wnt 
target gene, Sox9, decreased (Figure 2c).  These results indicate that the cultured gastric 
epithelial cells underwent differentiation through passage and 6 days culture.  Importantly, 
the miR-7 expression level increased significantly on day 6, to 6.5-fold the level observed 
on day 2.   
We next examined the miR-7 level in the stomach during development.  The 
expression level of miR-7 in the stomach increased significantly in the 14-day-old and adult 
mice, to more than 6-fold of that in E15 embryos (Figure 2d).  Conversely, expression of 
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CD44, one of the Wnt target genes, decreased significantly during development.  We 
confirmed by an immunohistochemistry that most epithelial cells in the gastric mucosa 
were Ki-67 positive on days 0 and 7, while the proliferating cells were limited to the gland 
neck on day 14 and in adult mice (Figure 2e).  Accordingly, the ratio of undifferentiated 
epithelial cells decreased during development.  Taken together, these results indicate that 
miR-7 expression is induced in gastric epithelial cells during differentiation. 
 
Tumor suppressor role of miR-7 in gastric cancer development 
We next examined the miR-7 levels in human gastric cancers by real-time RT-PCR.  The 
expression of miR-7 was downregulated in 18 out of 28 human gastric cancer tissue 
samples (64%) compared with paired non-tumor stomach tissue samples (Figure 3a), 
suggesting that miR-7 has a tumor suppressor role in a subpopulation of gastric cancers.  
We next examined expression level of IL-1 and TNF-, major proinflammatory cytokines, 
and compared them with the miR-7 level.  Importantly, expression levels of miR-7 were 
inversely correlated to those of IL-1 or TNF-, suggesting that downregulation of miR-7 
is related to the severity of inflammatory responses (Figure 3b).  We also found that miR-7 
was markedly downregulated in 4 out of 9 gastric cancer cells lines (Figure 3c).   
To examine the tumor suppressor role of miR-7 in gastric tumorigenesis, we 
transfected the precursor of miR-7, pre-miR-7, into AZ-521 and Kato-III gastric cancer 
cells and examined their proliferation and soft agar colony formation.  We confirmed that 
pre-miR-7 transfection into the reporter vector-transfected cells resulted in a significant 
decrease in luciferase activity, indicating an increase of mature miR-7 level (Supplementary 
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Figure 1).  Transfection of pre-miR-7 significantly decreased cell proliferation in both cell 
lines compared with control vector-transfected cells (Figure 3d).  Moreover, pre-miR-7 
transfection significantly suppressed the soft agar colony formation in both cell lines 
(Figure 3e and f).  These results strongly suggest that miR-7 has a tumor suppressor role 
in gastric cancer development. 
 
Repression of miR-7 in gastric cancer cells by macrophage-derived factor(s) 
We detected primary (pri)-miR-7-1, pri-miR-7-2 and pri-miR-7b in the mouse normal 
stomach by real-time RT-PCR (Supplementary Figure 2), suggesting that mature miR-7 is 
processed from all these primary miR-7 in the normal gastric mucosa.  MiR-7-1 is located 
in the intron of the Hnrnpk gene, and a CpG island is found in the promoter region of 
Hnrnpk (Supplementary Figure 3a).  On the other hand, we could not determine CpG 
islands that regulate the transcription of miR-7-2 and miR-7b.  We thus examined DNA 
methylation in the CpG islands in the Hnrnpk promoter region.  Notably, DNA 
methylation levels in K19-C2mE gastritis and Gan mouse tumor tissues were not increased 
compared with the wild-type mouse stomach (Supplementary Figure 3a).  Consistently, 
DNA methylation was not detected in the promoter region of the HNRNPK gene in the 
human gastric cancer tissues (Figure 4a).  We also examined the trimethylation of histone 
H3 at lysine 27 (H3K27me3) in the upstream CpG islands of Hnrnpk.  However, the 
H3K27me3 level was not increased in the mouse gastritis and gastric tumors compared 
with the wild-type stomach (Figure 4b).  These results indicate that DNA methylation and 
trimethylation of H3K27 are not involved in the downregulation of miR-7-1.  Moreover, 
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the genomic region including miR-7-1 was not deleted in human gastric cancer cells 
(Supplementary Figure 3b), suggesting that miR-7 downregulation in gastric cancer is not 
caused by genomic deletion.   
We next examined whether activated macrophages play a role in downregulation of 
miR-7, because the major source of proinflammatory cytokines in gastric tumors are 
macrophages (Oshima et al., 2004; Oshima et al., 2011).  To monitor the miR-7 activity, 
reporter vector-transfected cells were used.  We confirmed that the luciferase activity was 
increased significantly when miR-7 inhibitor was transfected into the reporter 
vector-transfected Kato-III cells (Supplementary Figure 1c), indicating that the luciferase 
reporter system was working.  Reporter cells were then treated with the conditioned 
medium of LPS-stimulated RAW264 cells [CM(+)] or unstimulated RAW264 cells [CM(-)].  
Importantly, the luciferase activity increased significantly when cells were stimulated with 
CM(+), while the luciferase activity was not changed in the control vector-transfected cells 
(Figure 4c).  Similar results were obtained when CM(+) and CM(-) were prepared using 
mouse intraperitoneal macrophages.  These results indicate that activated 
macrophage-derived factor(s) caused the miR-7 downregulation in gastric cancer cells. 
To identify the macrophage-derived factor(s) that suppress miR-7 expression, the 
reporter cells were stimulated with TNF-, IL-1, IL-6 or PGE2.  However, none of these 
factors caused an increase in the luciferase activity (Supplementary Figure 4).  We thus 
fractionated the CM(+) by ultrafiltration, and separated by molecular weight.  Interestingly, 
a CM(+) fraction of < 3 kDa significantly increased the luciferase activity to a similar level 
as that induced by whole CM(+), whereas the other CM(+) fractions did not (Figure 4d).  
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Moreover, the luciferase activity was still increased when CM(+) was prepared under 
co-treatment of RAW264 cells with LPS and a COX-2 inhibitor, celecoxib.  We confirmed 
the decreased level of miR-7 by real-time RT-PCR in the CM(+)- or CM(+) fraction < 3 
kDa-treated AZ521 cells (Figure 4e).  These results indicate that small molecule(s) (< 
3kDa) derived from activated macrophages are responsible for the miR-7 repression in 
gastric cancer cells, and that such small molecule(s) are expressed in activated 
macrophages in a COX-2/PGE2-independent manner. 
 
Downregulation of miR-7 in the stomach by inflammatory responses 
We next examined whether inflammatory responses are responsible for the miR-7 
downregulation in the stomach using different mouse models.  The stomachs of wild-type 
mice were infected with Helicobacter felis, and submucosal inflammatory infiltration and 
mucosal macrophage accumulation were confirmed at 20 weeks after the infection (Figure 
5a, b).  Notably, the miR-7 expression level was significantly decreased in the H. 
felis-infected inflamed gastric mucosa (Figure 5c).   
We recently showed that inflammatory responses and macrophage infiltration were 
suppressed in the K19-C2mE mouse gastritis and Gan mouse tumors when mice were 
maintained under germfree conditions (Figure 5d, and Oshima et al., 2011).  Notably, the 
miR-7 expression levels were increased significantly in germfree K19-C2mE and Gan mice 
compared with the levels of SPF mice (Figure 5e).  These in vivo experiments suggest that 
inflammatory responses are responsible for the miR-7 downregulation in the stomach, 




Inflammation-dependent upregulation of miR-7 target genes in gastric tumors 
The epidermal growth factor receptor (EGFR) mRNA is one of the miR-7 target genes 
(Kefas et al., 2008; Webster et al., 2009).  We thus examined the EGFR expression levels 
in the pre-miR-7-transfected Kato-III and AZ521 gastric cancer cells.  As expected, EGFR 
expression level was decreased significantly by pre-miR-7 transfection in both cell lines 
(Figure 6a), suggesting that suppression of EGFR expression is one of the tumor suppressor 
mechanisms of miR-7 against gastric cancer development.   
To identify novel miR-7 target genes that are upregulated in the inflammatory 
microenvironment, we searched for putative miR-7 target genes from the upregulated gene 
set in both K19-C2mE mouse gastritis and Gan mouse gastric tumors using the results of 
the microarray analyses (Itadani et al., 2009).  We found that the Lphn2, Basp1, and Mafg 
genes have conserved miR-7 target sequences in their 3’ UTR in both mouse and human 
mRNAs (Figure 6b).  Notably, expression of these genes was significantly increased not 
only in the K19-C2mE mouse gastritis and Gan mouse tumors, but also in K19-Nog/C2mE 
mouse gastric hamartomas (Figure 6c).  The gastric mucosa and tumors in these strains are 
inflamed as a result of the induction of the COX-2/PGE2 pathway (Oshima et al., 2004, 
2006, and 2009), suggesting that downregulation of miR-7 in inflammatory lesions is 
involved in upregulation of these genes.  Notably, transfection of pre-miR-7 into Kato-III 
cells resulted in a significant decrease of LPHN2, BASP1, and MAFG expression (Figure 
6d).  Moreover, we constructed luciferase reporter plasmids that contained the 3’ UTR 
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fragment of the putative miR-7 target genes, and transfected these vectors into Kato-III 
cells.  Consistent with the real-time RT-PCR results, the luciferase activities of the reporter 
vector-transfected cells decreased significantly when cells were co-transfected with 
pre-miR-7 (Figure 6e).  Taken together, these results indicate that these three genes are 
miR-7 targets.   
Finally, we examined expression of LPHN2, BASP1, and MAFG in human gastric 
cancers by real-time RT-PCR and compared their expression with the miR-7 expression 
levels.  We found that the expression levels of miR-7 and LPHN2, BASP1, MAFG were 
inversely correlated (Figure 6f).  Accordingly, it is possible that inflammation causes 
induction of these genes in human gastric cancers through downregulation of miR-7, which 




It has been shown that miR-155 and miR-21, which function as oncogenes, are 
induced by inflammatory pathways, providing a link between inflammation and cancer (Tili 
et al., 2007; O’Connell et al., 2007; Iliopoulos et al., 2010).  Consistently, we found 
inflammation-dependent induction of miR-155 and miR-21 in mouse gastric tumors.  On 
the other hand, miR-145 and miR-7, which function as tumor suppressors, are 
downregulated in both the mouse gastritis and gastric tumor tissues.  Moreover, we found 
that the miR-7 levels are inversely correlated with the levels of proinflammatory cytokines, 
suggesting that the severity of inflammatory response is related to miR-7 downregulation.  
It is therefore possible that inflammation can promote tumorigenesis both by the 
upregulation of oncogenic miRNAs and by the downregulation of tumor suppressor 
miRNAs, possibly through different mechanisms.  Such alterations of cancer-related 
miRNA expression likely link inflammation and cancer. 
It has been reported that miR-7 plays a tumor suppressor role in a variety of cancers 
including brain tumors, breast cancer, and lung cancer (Kefas et al., 2008; Reddy et al., 
2008; Webster et al., 2009), and we herein showed that miR-7 also functions as a tumor 
suppressor in gastric cancer.  Interestingly, in the normal stomach, miR-7 expression is 
induced during the differentiation of gastric epithelial cells, suggesting a role of miR-7 in 
the regulation of epithelial cell differentiation.  It has also been reported that miR-7 
expression is induced during the differentiation of intestinal epithelial cells (Nguyen et al., 
2010) and cortical neurons (Chen et al., 2010).  These results collectively suggest that 
miR-7 plays a role in regulating cell differentiation in a variety of organs.  It is therefore 
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conceivable that the suppression of miR-7 expression is required for the maintenance of the 
undifferentiated status of stem or progenitor cells in these organs.   
The present results suggest the possibility that inflammation suppresses epithelial cell 
differentiation through repression of miR-7.  It is not surprising that the inflammatory 
response suppresses cell differentiation and enhances proliferation when regeneration is 
required in injured tissues.  It has also been shown that a disruption of toll-like receptor 
signaling causes an impairment of tissue repair by intestinal epithelial cells 
(Rakoff-Nahoum et al., 2004).  Moreover, activated macrophages are important niche 
components for intestinal epithelial progenitors in regenerative responses (Pull et al., 2005).  
Therefore, it is conceivable that downregulation of miR-7 leads to suppression of 
differentiation, inducing the proliferation of undifferentiated epithelial cells in the 
inflammatory microenvironment.   
Although several target genes of miR-7 have been identified, it is still unclear how 
miR-7 regulates differentiation.  EGFR is one of the important miR-7 target genes, and is 
at least partially responsible for its tumor suppressor role (Kefas et al., 2008).  Moreover, 
p21-activated kinase 1, Raf1, and the insulin-like growth factor 1 receptor have also been 
identified as miR-7 target genes that are upregulated in cancer cells (Reddy et al., 2008; 
Webster et al., 2009; Jiang et al., 2010).  Although most of these gene products contribute 
to cancer cell proliferation, we believe that miR-7 inhibits expression of other factors that 
play a role in the maintenance of the undifferentiated status of epithelial cells.  In the 
present study, we identified three novel miR-7 target genes that are upregulated in gastric 
cancers in an inflammation-dependent manner.  LPHN2 is a G protein-coupled receptor 
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that binds -latrotoxin (Ichtchenko et al., 1999), while BASP1 is implicated in neurite 
outgrowth (Korshunova et al., 2008).  MAFG is one of the small Maf proteins that are 
important for antioxidant responses (Katsuoka et al., 2005).  Although it remains to be 
investigated, it is of interest to examine whether these molecules play any role in the 
differentiation or tumorigenesis of gastric epithelial cells.   
We examined the mechanisms responsible for the miR-7 downregulation in gastric 
tumor cells.  Helicobacter pylori infection induces chronic gastritis, resulting in induction 
of DNA methylation (Niwa et al., 2010).  The expression of miR-34b/c is suppressed by 
DNA methylation in H. pylori-associated gastric cancer cells (Suzuki et al., 2010).  
Moreover, H3K27me3 leads to tumor-suppressor gene silencing in cancer (Kondo et al., 
2008).   However, we showed that downregulation of miR-7 is not caused by genomic 
deletion nor by epigenetic mechanisms, but through stimulation by macrophage-derived 
factor(s).  Several mechanisms for the regulation of miR-7 expression have been reported.  
For example, miR-7 transcription is directly induced by HoxD10 (Reddy et al., 2008) or 
c-Myc (Chou et al., 2010).  Splicing factor SF2/ASF binds the pri-miR-7 to enhance its 
cleavage by Drosha (Wu et al., 2010).  Accordingly, it is conceivable that 
macrophage-derived molecule(s) directly downregulate the miR-7 expression or indirectly 
suppress the miR-7 expression through modulation of these regulation systems.  The 
identification of responsible macrophage-derived molecule(s) will provide a novel 
mechanism by which macrophages promote tumorigenesis.   
In conclusion, we showed that inflammation simultaneously induces the upregulation 
of oncogenic miRNAs and the downregulation of tumor suppressor miRNAs, which 
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promote tumorigenesis.  The expression of miR-7 is induced during differentiation of 
gastric epithelial cells, suggesting a role for miR-7 in the regulation of epithelial cell 
differentiation.  Accordingly, it is possible that the downregulation of miR-7 contributes to 
suppression of differentiation, resulting in the promotion of gastric tumorigenesis.  
Moreover, small molecule(s) expressed by activated macrophages are responsible for 
miR-7 repression, providing a link between inflammation and cancer.  Therefore, miR-7 
may be useful for devising a new preventive or therapeutic strategy against gastric cancer 
through the induction of cancer cell differentiation. 
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Materials and methods 
Mouse models 
Construction of K19-C2mE and Gan (K19-Wnt1/C2mE) mice was described previously 
(Oshima et al., 2004, and 2006).  Briefly, K19-C2mE mice express Ptgs2 and Ptges in 
gastric epithelial cells, whereas Gan mice express Ptgs2, Ptges and Wnt1.  For the 
expression analyses, the K19-C2mE mouse gastritis and Gan mouse gastric tumor samples, 
and wild-type mouse stomach tissues were obtained at 30~40 weeks of age.  Germfree 
mouse colonies were constructed as described previously (Oshima et al., 2011), and the 
histology and miR-7 expression were examined at 55 weeks of age (n=5).  Helicobacter 
felis (ATCC 49179) were inoculated at 108/mouse into the wild-type mice at 6~8 weeks of 
age, and the histology and miRNA expression were examined at 20 weeks after infection 
(n=6).  All animal experiments were carried out according to a protocol approved by the 
Committee on Animal Experimentation of Kanazawa University. 
 
Microarray analysis 
Total RNA was extracted from mouse stomachs (n=3) using ISOGEN (Nippon Gene, 
Tokyo, Japan), pooled with the same genotype mouse RNAs, labeled with Cy3, and 
hybridized to Mouse miRNA microarray Rel. 12.0 (Agilent Technologies, Santa Clara, CA).  
The raw data were normalized using the GeneSpring GX software program (Agilent 
Technologies), and the expression levels of miRNAs in gastritis and gastric tumor tissues 
were compared with those in the wild-type mouse stomach.  Transcripts with low signals 
(less than three-fold of the background level) were not used for further analyses.  
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Expression of miRNAs was further examined by real-time RT-PCR using RNA samples 
independently prepared from a different set of wild-type, K19-C2mE and Gan mice (n=5 
for each genotype). 
The results of cDNA microarray data sets of K19-C2mE, Gan, and K19-Nog/C2mE 
mice were deposited into the Gene Expression Omnibus (GEO), as accession number 
GSE16902 (Itadani et al., 2009), and were searched for the presence of novel miR-7 target 
genes using the TargetScan 5.1 program (http://www.targetscan.org).   
 
Real-time RT-PCR 
Paired gastric cancer and non-tumor stomach tissue samples were obtained from 28 
patients during surgery at Kanazawa University Hospital, Japan.  Fresh frozen tissues 
were used for the expression analyses.  Clinicopathological data of patients are shown in 
Supplementary Table 3.  Human normal gastric epithelial cells were prepared by isolating 
the gastric glands from normal stomach tissues (n=4) as described previously (Cheng et al., 
1984).  Approval for this project was obtained from the Kanazawa University Medical 
Ethics Committee, and written informed consent was obtained before specimen collection.  
Mouse stomachs were obtained from E15 wild-type mouse embryos, and day 0, day 7, day 
14 and adult mice (n=3 for each).  Total RNAs were extracted from the tissues or cells 
using ISOGEN (Nippon Gene), and the cDNAs for miRNAs and mRNAs were constructed 
using QuantiMir RT Kit (System Bioscience, Mountain View, CA) and the PrimeScript RT 
reagent Kit (Takara, Tokyo, Japan), respectively.  Real-time RT-PCR was performed using 
SYBR Premix Ex TaqII (Takara, Tokyo, Japan) and Stratagene Mx3000P (Agilent 
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Technologies).  Sno202 and U44 were used as endogenous miRNA controls for mice and 
humans, respectively, whereas -actin was used for endogenous mRNA control.  The 
primer sequences for the miRNAs are shown in Supplementary Table 4.  The primers for 
mRNAs were purchased from Takara (Tokyo, Japan). 
 
Cell culture experiments 
Mouse glandular stomachs were treated with 0.1% collagenase for 30 min at 37oC, 
followed by centrifugation at 20 g for 3 min to isolate gastric glands.  For the primary 
culture, isolated gastric glands were digested with trypsin and seeded on collagen-coated 
dishes as described (Oshima et al., 2004).  On day 2, the primary cultured cells were 
treated with 10mM EDTA-PBS and passaged.  The primary cultured cells on day 2 (P0) 
and day 6 (P1) were used for the expression analysis.  Human gastric cancer cell lines, 
AGS (ATCC), AZ521, MKN74, MKN45, NUGC4, HCT-111-TC, SH-10-TC (RIKEN 
BioResource Center, Tsukuba, Japan), Kato-III, and MKN7 (Cell Resource Center for 
Biomedical Research, Tohoku University, Japan) were used in this study.   
The pre-miR miRNA-7 (Pre-miR-7), pre-miR negative control (Pre-miR-NC) and 
anti-miR-7 inhibitor (Ambion, Austin, TX) were used for transfection.  The cell 
proliferation rate was measured using the Cell Counting Kit-8 (Dojindo, Kumamoto, Japan).  
For the soft agar colony formation assay, cells were suspended in culture medium with 
0.33% agar, and seeded in a 6-well plate.  After 21 days of culture, soft agar was stained 
with Giemsa solution (Wako, Osaka, Japan).   
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Histological and immunohistochemical analyses 
Tissues were fixed in 4% paraformaldehyde, embedded and sectioned at 4-m 
thickness.  The sections were stained with H&E.  Antibodies against Ki-67 
(DakoCytomation, Carpentria, CA) and F4/80 (Serotec, Oxford, UK) were used as the 
primary antibodies.  Immunostaining signals were visualized using the Vectastain Elite Kit 
(Vector Laboratories, Burlingame, CA), and the MOM kit (Vector Laboratories) was used 
to minimize the background staining signals. 
 
Methylation-specific PCR (MSP) analysis 
The methylation status of miR-7-1 in human gastric cancer and non-tumor tissues was 
examined by MSP analysis as described (Yamashita et al., 2008).  The MSP was 
performed with a primer set specific for the methylated or unmethylated sequence (Me or 
Un set in Supplementary Table 4).  DNA methylated by SssI methylase (New England 
Biolabs) and DNA amplified by a GenomiPhi DNA amplification kit (GE Healthcare 
Bio-Science) were used as methylated and unmethylated controls, respectively. 
 
Chromatin immunoprecipitation (ChIP) analyses 
Histone modifications were examined by ChIP assay as described (Yamashita et al., 
2008; Takeshima et al., 2009).  Briefly, gastric epithelial cells of wild-type, K19-C2mE, 
and Gan mice (n=3 for each genotype) were cross-linked with 1% formaldehyde, and 
sheared chromatin by Bioruptor UCD-250 (Cosmo Bio, Tokyo, Japan).  The samples were 
incubated with an antibody against H3K27me3 (07-449, Millipore, Billerica, MA), and 
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genomic DNA samples were used for the quantitative ChIP-PCR analyses.  The primer set 
was designed for the upstream CpG islands of miR-7-1 (Supplementary Table 4). 
 
Luciferase reporter assay  
Construction of the miR-7 luciferase reporter vector (miR-7 Luc) and control vector 
(control Luc) are shown in Supplementary Figure 1.  Luciferase reporter vectors for the 
LPHN2, BASP1, and MAFG genes were constructed by subcloning 3’ UTR fragments of 
the respective human genes into the pGL3 plasmid (Promega, Madison, WI).  PCR primer 
sequences for cloning 3’ UTR of the respective genes and amplified fragment lengths are 
indicated in Supplementary Table 4.  The luciferase activity was measured using a 
Luciferase Assay System (Promega) and the levels were normalized to the total protein 
levels detected by Pierce 660 nm Protein Assay (Thermo Scientific, Yokohama, Japan).  
RAW264 cells (RIKEN BioResource Center) and mouse intraperitoneal macrophages were 
stimulated with 10 ng/ml of LPS (Sigma) for 24 hours and the conditioned medium was 
collected as CM(+).  The conditioned medium of the unstimulated macrophages was 
collected as CM(-).  The conditioned medium of the LPS-stimulated and COX-2 inhibitor 
celecoxib (Pfizer)-treated (10 M) RAW264 cells was collected as CM(+/coxib).  The 
CM(+) was fractionated by ultrafiltration using Centricon Plus-70 (Millipore, Billerica, 
MA) to prepare CM(+) >100 kDa, 30~100 kDa, 3~30 kDa, and < 3 kDa.  Cells were 
stimulated with CM at a 50% concentration.   
 
Western blotting analysis 
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Cells were transfected with pre-miR-7 or the pre-miR-NC, lysed at 24 hours after 
transfection, and 10 g of protein were separated in 7.5% SDS-polyacrylamide gels.  An 
antibody against EGFR (Cell Signaling Technology, Danvers, MA) was used as the primary 
antibody.  Anti--actin (Sigma) was used as an internal control.  The ECL detection 
system (GE Healthcare, Buckinghamshire, UK) was used to detect the signals, and the band 
intensities were quantified using the ImageJ application (NIH). 
 
Statistical analysis 
The data were analyzed by the unpaired t-test using the Microsoft Excel software 
program (Microsoft).  A value of p < 0.05 was considered to be statistically significant. 
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Figure legends 
Figure 1.  Inflammation-dependent dysregulation of miRNA expression in mouse gastric 
tumors.  (a) Venn diagrams of the miRNAs that were upregulated (> 2.0) and 
downregulated (< 0.5) in Gan mouse gastric tumors and/or K19-C2mE mouse gastritis 
samples as determined by the microarray analysis are shown.  The miRNAs listed in 
boxes were upregulated (left) or downregulated (right) in both the gastric tumor and 
gastritis tissue samples.  (b) The relative expression levels of selected miRNAs (indicated 
in bold in the list) for K19-C2mE mouse gastritis (blue bars) and Gan mouse gastric tumors 
(red bars) compared to the wild-type levels examined by real-time RT-PCR are shown as 
the log10 ratios.  *p < 0.05 versus the wild-type level.  The expression levels of miRNAs 
were normalized to the Sno202 level.  (c) The miRNA levels in Gan mouse tumors 
relative to those in K19-C2mE gastritis tissues examined by the microarray analysis are 
shown.  Red and blue bars indicate upregulated (> 2.0) and downregulated (< 0.5) 
miRNAs, respectively, in Gan mouse tumors. 
 
Figure 2.  The induction of miR-7 expression in the differentiated gastric epithelial cells.  
(a) A representative photograph of isolated gastric glands from wild-type mice (top, arrows).  
The expression levels of miR-7 in the isolated gastric glands of K19-C2mE and Gan mice 
relative to the wild-type level are shown (mean  s.d.) (bottom).  *p < 0.05.  (b) 
Representative photographs of the primary cultured gastric epithelial cells on day 2 
(passage 0: P0) and day 6 (passage 1: P1) (original magnification, 100).  Arrows in P1 
indicate mucin-containing enlarged cells on day 6.  (c) The levels of Muc6, Muc5AC, and 
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Sox9 mRNA and miR-7 in the primary cultured gastric epithelial cells on day 6 (closed 
bars) relative to the levels on day 2 (gray bars) are shown (mean  s.d.).  *p < 0.05 versus 
the day 2 level.  (d) The expression levels of miR-7 (gray bars) and CD44 (open bars) in 
the stomach at the indicated ages relative to the levels in E15 embryos are shown (mean  
s.d.).  *p < 0.05 versus the E15 level.  The expression levels of miR-7 were normalized 
to the Sno202 level.  (e) Representative photographs of Ki-67 immunostaining in the 
glandular stomach of mice at the indicated ages.  Asterisks indicate proliferative zones.  
Scale bars indicate 50 m.   
 
Figure 3.  The tumor suppressor roles of miR-7 in gastric cancer cells.  (a) The relative 
miR-7 expression levels in the human gastric cancer tissue samples to the level of 
non-tumor stomach tissue samples are shown as the Log10 ratios.  The indicated numbers 
correspond to the patient ID in the clinicopathological data (Supplementary Table 3).  (b) 
Comparison of the relative expression levels of miR-7 and IL-1 (left) or TNF- (right) in 
gastric cancer tissues to the non-tumor stomach tissue levels in each patient is shown.  Red 
and blue lines indicate that the expression of miR-7 was increased (> 1.0) and decreased 
(<1.0) in the gastric cancers, respectively.  (c) The relative expression levels of miR-7 in 
gastric cancer cell lines compared to the mean level in the human normal gastric epithelial 
cells are shown as the Log10 ratios.  The expression levels of miR-7 were normalized to 
that of U44.  (d) The proliferation of control (gray bars) and pre-miR-7-transfected 
(closed bars) AZ521 cells and Kato-III cells at the indicated culture days are shown (mean 
 s.d.).  *p < 0.05.  (e) Representative photographs of soft agar colonies in 6 well plates 
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showing the pre-miR-NC- (left) and pre-miR-7-transfected (right) Kato-III cells.  (f) The 
mean numbers of soft agar colonies larger than the indicated diameters in each well of 
6-well plate of control (gray bars) and pre-miR-7-transfected (closed bars) AZ521 cells and 
Kato-III cells are shown (mean  s.d.).  *p < 0.05.   
 
Figure 4.  The mechanism responsible for the downregulation of miR-7 in gastric tumor 
cells.  (a) Representative results of methylated (top) or unmethylated (bottom) 
status-specific PCR for miR-7-1.  Lanes 1-12, human gastric cancer samples; lanes 13-22, 
non-tumor stomach samples; lane 23, methylated DNA control; lane 24, unmethylated 
DNA control; and lane 25, water control.  (b) The results of ChIP-PCR analyses of 
miR-7-1 and the house-keeping genes, Gapdh and Eef1a1, for H3K27me3 in the gastric 
mucosa of respective genotype mice.  The percentages of immunoprecipitated (IP)/whole 
cell extracts (WCE) are shown for each primer set.  (c) The luciferase activities of miR-7 
Luc- or control Luc-transfected AZ521 reporter cells stimulated with CM(+) (gray bars) 
relative to those with CM(-) (open bars) are shown (mean  s.d.).  *p < 0.05.  
Conditioned medium was prepared from RAW264 cells (left) or intraperitoneal 
macrophages (right).  (d) The luciferase activities of miR-7 Luc-transfected AZ521 
reporter cells stimulated with whole CM(+) (closed bars), CM(+) fractionated to the 
indicated molecular sizes (gray bars), or fractionated CM(+) to < 3kDa collected from 
celecoxib-treated and LPS-stimulated macrophages (light gray bar) relative to the control 
level (open bar) are shown (mean  s.d.).  *p < 0.05 versus the control level.  (e) The 
relative miR-7 expression levels examined by real-time RT-PCR in AZ521 cells stimulated 
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with whole CM(+) or fractioned CM(+) < 3 kDa relative to the control level are shown 
(mean  s.d.).  *p < 0.05 versus the control level.  The expression levels of miR-7 were 
normalized to the U44 level.  
 
Figure 5.  The inflammation-induced miR-7 expression in the mouse stomachs.  (a) 
Histology of the wild-type mouse normal glandular stomach (top) and H. felis-infected 
inflamed glandular stomach (bottom).  Arrows and inset indicate submucosal 
inflammatory cell infiltration.  Scale bars indicate 0.5 mm.  (b) Immunostaining of F4/80 
in the normal glandular stomach (top) and H. felis-infected glandular stomach (bottom).  
Arrowheads indicate macrophages.  Scale bars indicate 100 m.  (c) The miR-7 
expression level of H. felis-infected gastric mucosa (gray bar) relative to that of the control 
stomach (open bar) is shown (mean  s.d.).  *p < 0.05.  (d) Immunostaining of F4/80 in a 
SPF control Gan mouse tumor (top) and a germfree Gan mouse tumor (bottom).  
Arrowheads indicate macrophages.  Scale bars indicate 100 m.  (e) The expression 
levels of miR-7 in SPF (gray bars) and germfree (closed bars) K19-C2mE mouse gastritis 
and Gan mouse gastric tumors relative to the SPF wild-type stomach levels are shown 
(mean  s.d.).  *p < 0.05.  The expression levels of miR-7 were normalized to the 
Sno202 level.    
 
Figure 6.  Inflammation-dependent upregulation of miR-7 target genes.  (a) 
Representative results of the Western blotting analysis of EGFR in Kato-III cells (top left) 
and AZ521 cells (top right) transfected with pre-miR-NC and pre-miR-7.  The results for 
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two independently prepared samples are shown.  -Actin was used as an internal control.  
The relative band intensities of the Western blotting results are shown in the bar graph 
(mean  s.d.) (bottom).  *p < 0.05 versus the control level.  (b) The alignment of the 
miR-7 target sequences in the 3’-UTR of Lphn2, Basp1, and Mafg in human and mouse 
mRNAs.  The seed match sequences for miR-7 are indicated in red.  (c) The expression 
levels of the indicated genes in K19-C2mE mouse gastritis (green bars), Gan mouse gastric 
tumors (yellow bars), and K19-Nog/C2mE mouse gastric hamartomas (blue bars) relative 
to the wild-type levels (gray bars) are shown (mean  s.d.).  *p < 0.05 versus the 
wild-type level.  The results were extracted from the microarray data set (Gene Expression 
Omnibus (GEO), accession GSE16902).  (d) The expression levels of the indicated genes 
examined by real-time RT-PCR in the pre-miR-7-transfected Kato-III cells (closed bar) 
relative to those of the control cells (gray bar) are shown (mean  s.d.).  *p < 0.05 versus 
control level.  (e) The relative luciferase activity levels of pre-miR-7-transfected reporter 
cells (closed bars) to the levels of control pre-miR-NC-transfected reporter cells (gray 
bars) are shown.  The target genes for the respective luciferase reporter vectors are 
indicated.  *p < 0.05 versus the control level.  (f) Comparison of the relative expression 
levels of miR-7 and LPHN2 (left), BASP1 (center) or MAFG (right) in human gastric 
cancers to the non-tumor stomach levels is shown.  Red and blue lines indicate that miR-7 
was increased (>1.0) and decreased (< 1.0) in gastric cancers, respectively. The expression 
levels of miR-7 were normalized to the U44 level.   






